Icon

What is the
connection?

Atherosclerotic cardiovascular disease (ASCVD) is a type of heart disease caused by consistent high levels of bad cholesterol (LDL-C) in the blood that lead to the buildup of plaque on the walls of the arteries. In people with ASCVD, the plaque buildup has resulted in problems related to bad cholesterol, such as:

  • heart attack

  • stroke

  • blockages within the arteries, causing chest pain

If you have ASCVD, it's important to lower your bad cholesterol.

It is not known if LEQVIO® can decrease problems related to high levels of bad cholesterol, such as heart attacks or stroke.

Thumbnail

Struggling to
lower your bad
cholesterol (LDL-C)?

You're doing everything you can to lower your bad cholesterol. Diet. Exercise. Statins. Or even another cholesterol-lowering treatment. But sometimes your current treatment, with healthy food choices and more physical activity, still isn't enough.

And while you can't control factors like age or genetics, you can partner with your health care provider to help manage your treatment.

Icon

Learn how Leqvio works to help lower bad cholesterol (LDL-C)

Want to know more? This brochure is here to help you get the answers you're looking for.

Form

Download the LEQVIO Patient Brochure

English Español

WHAT IS LEQVIO?

Keeping bad cholesterol (LDL-C) low is possible
with LEQVIO.

Find out how arrow

INDICATION AND IMPORTANT SAFETY INFORMATION

COLLAPSE

EXPAND

IMPORTANT SAFETY INFORMATION

The most common side effects of LEQVIO were: injection site reaction (including pain, redness, and rash), joint pain, urinary tract infection, diarrhea, chest cold, pain in legs or arms and shortness of breath.

These are not all the possible side effects of LEQVIO. Ask your health care provider for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-10881-800-FDA-1088.

Please see the LEQVIO full Prescribing Information.

What is LEQVIO?

LEQVIO (inclisiran) is an injectable prescription medicine used along with diet and other lipid-lowering medicines in adults who need additional lowering of "bad" cholesterol (LDL-C) and have known cardiovascular disease and/or heterozygous familial hypercholesterolemia (HeFH), an inherited condition that causes high levels of LDL-C. It is not known if LEQVIO can decrease problems related to high cholesterol, such as heart attacks or stroke.